专利检索 ap:("INSERM (Institut National de la Santé et de la Recherche Médicale)" OR "Institut Curie" OR "CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE -CNRS-") AND inv:"ALLAN, Rhys" 第 1 页

1.

发明公开
METHODS AND PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF TH2 MEDIATED DISEASES 审中-公开

公开(公告)号：EP3616690A1

公开(公告)日：2020-03-04

申请号：EP19202570.8

申请日：2012-10-03

申请人： INSERM (Institut National de la Santé et de la Recherche Médicale) , Institut Curie , CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE -CNRS-

发明人： AMIGORENA, Sebastian , ALLAN, Rhys , SCHREIBER, Heidi , ZUEVA, Elina , ALMOUZNI, Geneviève

IPC分类号： A61K31/00 , A61K31/4995 , A61P37/06 , A61P37/08 , A61P11/06 , G01N33/50 , G01N33/68

摘要： The present invention relates to methods and pharmaceutical composition for the treatment of T-helper type 2 (Th2)-mediated diseases. More particularly, the present invention relates to an inhibitor of the Suv39h1-HP1α silencing pathway for use in the treatment of a T-helper type 2 (Th2)-mediated disease, in particular allergic asthma.

2.

发明公开
METHODS AND PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF TH2 MEDIATED DISEASES 审中-公开
标题翻译：方法和药物组合物，TH2介导的疾病治疗

公开(公告)号：EP2764369A1

公开(公告)日：2014-08-13

申请号：EP12768811.7

申请日：2012-10-03

申请人： INSERM - Institut National de la Santé et de la Recherche Médicale , Institut Curie , Centre National de la Recherche Scientifique (CNRS)

发明人： AMIGORENA, Sebastian , ALLAN, Rhys , SCHREIBER, Heidi , ZUEVA, Elina , ALMOUZNI, Geneviève

IPC分类号： G01N33/68

CPC分类号： A61K31/548 , C12Q1/48 , G01N33/5023 , G01N33/6875 , G01N33/6893 , G01N2333/91011 , G01N2500/00 , G01N2500/02 , G01N2500/10

摘要： The present invention relates to methods and pharmaceutical composition for the treatment of T-helper type 2 (Th2)-mediated diseases. More particularly, the present invention relates to an inhibitor of the Suv39h1-HP1a silencing pathway for use in the treatment of a T-helper type 2 (Th2)-mediated disease, in particular allergic asthma.